Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Cancer Type/Condition:
Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
Stage/Subtype:
Philadelphia chromosome positive childhood precursor acute lymphoblastic leukemia
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
Phase:
Phase IV
Type:
Treatment
Status:
Active
Age:
21 and under
Sponsor:
Other
Protocol IDs:
SCT 0208
, NCT00679536
2.
Single Versus Double Umbilical Cord Blood Transplantation in Children With High Risk Leukemia and Myelodysplasia
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
1 to 21
Sponsor:
NCI, NHLBI
Protocol IDs:
467
, BMT CTN 0501, 5 U01 HL69294-05, NCT00412360
3.
Imatinib Mesylate and Nilotinib After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
NCI, Pharmaceutical / Industry
Protocol IDs:
FHCRC-2223.00
, 6691, FHCRC-IR-6691, NOVARTIS-FHCRC-2223.00, NCT00702403
4.
A Phase II Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
1 to 21
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CA180-226
, EUDRACT: 2008-002260-33, NCT00777036
5.
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Under 60
Sponsor:
Other
Protocol IDs:
2008-0363
, NCT00857389
6.
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
8 to 75
Sponsor:
NHLBI
Protocol IDs:
090087
, 09-H-0087, NCT00859586
7.
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
0 to 65
Sponsor:
Other
Protocol IDs:
2009-0209
, NCT00990249
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
